Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-07

Clinical Trial Update: Hyperbaric Oxygen Therapy for Perianal Fistulizing Crohn's Disease Not Responsive or Intolerant to Conventional Care: HYPNOTIC Pilot Study [Phase 1, Phase 2]

View source ↗

Summary

Pilot study evaluating hyperbaric oxygen therapy for perianal fistulizing Crohn's disease not responding to conventional care; phase 1/2 with unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Inflammatory Bowel Disease (IBD) | Phase 1, Phase 2 | Status: UNKNOWN